MoonLake Immunotherapeutics (Non-dilutive financing)

Funding Details

Awarder: Inbox
Date Award: May 17, 2025
Vertical: Biotechnology
Funding URL: View Funding Page
Funding Amount:: $500,000,000

Company Info

Founding Year: 2021
Traction: MoonLake is progressing eight Phase 2 and Phase 3 clinical trials and will hold a Capital Markets Update to discuss the Hercules partnership and provide important clinical updates.
Company Description: MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
Market: Inflammatory diseases
Location: Zug, Switzerland
Coinvestors: Hercules Capital, Inc.

Links

Back to Home Back to Biotechnology Deals View Funding Announcement